Nicholas Coppard

423 total citations
6 papers, 188 citations indexed

About

Nicholas Coppard is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Nicholas Coppard has authored 6 papers receiving a total of 188 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Cellular and Molecular Neuroscience and 2 papers in Neurology. Recurrent topics in Nicholas Coppard's work include Mitochondrial Function and Pathology (4 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and DNA Repair Mechanisms (2 papers). Nicholas Coppard is often cited by papers focused on Mitochondrial Function and Pathology (4 papers), Parkinson's Disease Mechanisms and Treatments (2 papers) and DNA Repair Mechanisms (2 papers). Nicholas Coppard collaborates with scholars based in Germany, United Kingdom and United States. Nicholas Coppard's co-authors include Thomas Meier, David R. Lynch, Christian Rummey, Susan Perlman, William J. Weiner, Juha‐Matti Savola, Mika Leinonen, Peter A. LeWitt, Robert A. Hauser and Anthony P. Nicholas and has published in prestigious journals such as Brain, Neurology and Journal of Neurology.

In The Last Decade

Nicholas Coppard

6 papers receiving 184 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicholas Coppard Germany	4	132	116	100	24	15	6	188
Andrew McGarry United States	9	161 1.2×	121 1.0×	113 1.1×	7 0.3×	6 0.4×	23	220
Laetitia Schwab United Kingdom	3	85 0.6×	55 0.5×	48 0.5×	12 0.5×	15 1.0×	3	118
María Gabriela Otero United States	8	78 0.6×	129 1.1×	65 0.7×	48 2.0×	3 0.2×	13	234
Reem A. Alkhater Canada	6	90 0.7×	68 0.6×	64 0.6×	26 1.1×	11 0.7×	8	207
Veronica F. Colomer Gould United States	5	226 1.7×	233 2.0×	73 0.7×	42 1.8×	4 0.3×	5	317
Elina Makino United States	4	113 0.9×	210 1.8×	109 1.1×	111 4.6×	13 0.9×	5	357
Erica St. Lawrence United States	1	99 0.8×	209 1.8×	195 1.9×	40 1.7×	5 0.3×	2	361
Siv Vingill United Kingdom	7	126 1.0×	139 1.2×	153 1.5×	44 1.8×	18 1.2×	8	300
Naomi Lubarr United States	6	76 0.6×	54 0.5×	86 0.9×	14 0.6×	16 1.1×	13	169
Nandkishore R. Belur United States	6	72 0.5×	88 0.8×	207 2.1×	115 4.8×	14 0.9×	7	314

Countries citing papers authored by Nicholas Coppard

Since Specialization

Citations

This map shows the geographic impact of Nicholas Coppard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Coppard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Coppard more than expected).

Fields of papers citing papers by Nicholas Coppard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Coppard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Coppard. The network helps show where Nicholas Coppard may publish in the future.

Co-authorship network of co-authors of Nicholas Coppard

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Coppard. A scholar is included among the top collaborators of Nicholas Coppard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Coppard. Nicholas Coppard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

Buyse, Gunnar, et al.. (2016). A phase III double-blind, randomized, placebo-controlled study (SIDEROS) assessing the efficacy of idebenone in slowing the rate of respiratory function loss in patients with Duchenne muscular dystrophy receiving glucocorticoid steroids. Neuromuscular Disorders. 26. S157–S157. 3 indexed citations

Metz, Günther, et al.. (2014). A case report survey (CRS) on the natural history of visual acuity in patients with Leber’s hereditary optic neuropathy (LHON). Acta Ophthalmologica. 92(s253). 0–0. 2 indexed citations

Metz, Günther, Nicholas Coppard, Jonathan M. Cooper, et al.. (2013). Rating disease progression of Friedreich’s ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient database. Brain. 136(1). 259–268. 36 indexed citations

Klopstock, Thomas, Günther Metz, Patrick Yu‐Wai‐Man, et al.. (2012). Persistence of treatment effect of idebenone in Leber's Hereditary Optic Neuropathy. Acta Ophthalmologica. 90(s249). 0–0. 3 indexed citations

LeWitt, Peter A., Robert A. Hauser, Mei Lü, et al.. (2012). Randomized clinical trial of fipamezole for dyskinesia in Parkinson disease (FJORD study). Neurology. 79(2). 163–169. 68 indexed citations

Meier, Thomas, Susan Perlman, Christian Rummey, Nicholas Coppard, & David R. Lynch. (2011). Assessment of neurological efficacy of idebenone in pediatric patients with Friedreich's ataxia: data from a 6-month controlled study followed by a 12-month open-label extension study. Journal of Neurology. 259(2). 284–291. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact